EQUUS II INC
10-Q, EX-27.1, 2000-08-11
Previous: EQUUS II INC, 10-Q, 2000-08-11
Next: INCYTE GENOMICS INC, 10-Q, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 6

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   JUN-30-2000
<INVESTMENTS-AT-COST>                          173,228,907
<INVESTMENTS-AT-VALUE>                         170,355,167
<RECEIVABLES>                                    3,513,409
<ASSETS-OTHER>                                       4,885
<OTHER-ITEMS-ASSETS>                                     0
<TOTAL-ASSETS>                                 173,873,461
<PAYABLE-FOR-SECURITIES>                                 0
<SENIOR-LONG-TERM-DEBT>                                  0
<OTHER-ITEMS-LIABILITIES>                       74,257,022
<TOTAL-LIABILITIES>                             74,257,022
<SENIOR-EQUITY>                                  8,448,042
<PAID-IN-CAPITAL-COMMON>                        91,168,397
<SHARES-COMMON-STOCK>                            5,884,942
<SHARES-COMMON-PRIOR>                            6,107,669
<ACCUMULATED-NII-CURRENT>                                0
<OVERDISTRIBUTION-NII>                                   0
<ACCUMULATED-NET-GAINS>                         11,315,166
<OVERDISTRIBUTION-GAINS>                                 0
<ACCUM-APPREC-OR-DEPREC>                        (2,873,740)
<NET-ASSETS>                                    99,616,439
<DIVIDEND-INCOME>                                  643,619
<INTEREST-INCOME>                                1,949,197
<OTHER-INCOME>                                     244,231
<EXPENSES-NET>                                   2,124,712
<NET-INVESTMENT-INCOME>                            712,335
<REALIZED-GAINS-CURRENT>                         1,346,635
<APPREC-INCREASE-CURRENT>                       (1,773,152)
<NET-CHANGE-FROM-OPS>                              285,818
<EQUALIZATION>                                           0
<DISTRIBUTIONS-OF-INCOME>                                0
<DISTRIBUTIONS-OF-GAINS>                                 0
<DISTRIBUTIONS-OTHER>                                    0
<NUMBER-OF-SHARES-SOLD>                                  0
<NUMBER-OF-SHARES-REDEEMED>                        222,727
<SHARES-REINVESTED>                                      0
<NET-CHANGE-IN-ASSETS>                          (1,802,381)
<ACCUMULATED-NII-PRIOR>                                  0
<ACCUMULATED-GAINS-PRIOR>                                0
<OVERDISTRIB-NII-PRIOR>                                  0
<OVERDIST-NET-GAINS-PRIOR>                               0
<GROSS-ADVISORY-FEES>                            1,004,044
<INTEREST-EXPENSE>                                 793,969
<GROSS-EXPENSE>                                  2,124,712
<AVERAGE-NET-ASSETS>                           100,517,630
<PER-SHARE-NAV-BEGIN>                                16.61
<PER-SHARE-NII>                                        .12
<PER-SHARE-GAIN-APPREC>                                .23
<PER-SHARE-DIVIDEND>                                     0
<PER-SHARE-DISTRIBUTIONS>                                0
<RETURNS-OF-CAPITAL>                                     0
<PER-SHARE-NAV-END>                                  16.93
<EXPENSE-RATIO>                                       2.11


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission